MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

NCT00302471 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Comparator: MK0429
DRUG: Comparator: MK0429
DRUG: Comparator: MK0429
DRUG: Comparator: MK0429

Sponsor

Merck Sharp & Dohme LLC